Verrica Pharmaceuticals logo

Verrica Pharmaceuticals Share Price Today

(NASDAQ: VRCA)

Verrica Pharmaceuticals share price is $0.49 & ₹41.88 as on 18 Apr 2025, 2.30 'hrs' IST

$0.49

0.01

(2.36%)

Market is closed - opens 7 PM, 21 Apr 2025

View live Verrica Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Verrica Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Verrica Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Verrica Pharmaceuticals share price movements

  • Today's Low: $0.44
    Today's High: $0.49

    Day's Volatility :10.5%

  • 52 Weeks Low: $0.38
    52 Weeks High: $11.41

    52 Weeks Volatility :96.66%

Verrica Pharmaceuticals (VRCA) Returns

PeriodVerrica Pharmaceuticals IncSector (Health Care)Index (Russel 2000)
3 Months
-31.11%
-2.8%
0.0%
6 Months
-68.76%
-11.0%
0.0%
1 Year
-92.97%
-1.9%
0.0%
3 Years
-93.23%
-1.5%
-12.9%

Verrica Pharmaceuticals (VRCA) Key Statistics

in dollars & INR

Previous Close
$0.4792
Open
$0.467
Today's High
$0.4905
Today's Low
$0.439
Market Capitalization
$45.0M
Today's Volume
$374.3K
52 Week High
$11.41
52 Week Low
$0.3816
Revenue TTM
$7.6M
EBITDA
$-64.1M
Earnings Per Share (EPS)
$-1.48
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-1546.58%

How to invest in Verrica Pharmaceuticals Stock (VRCA) from India?

It is very easy for Indian residents to invest directly in Verrica Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Verrica Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Verrica Pharmaceuticals or VRCA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Verrica Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Verrica Pharmaceuticals shares which would translate to 1.744 fractional shares of Verrica Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Verrica Pharmaceuticals, in just a few clicks!

Returns in Verrica Pharmaceuticals (VRCA) for Indian investors in Rupees

The Verrica Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Verrica Pharmaceuticals investment value today

Current value as on today

₹9,361

Returns

₹90,639

(-90.64%)

Returns from Verrica Pharmaceuticals Stock

₹92,980 (-92.98%)

Dollar Returns

₹2,341 (+2.34%)

Indian investors sentiment towards Verrica Pharmaceuticals (VRCA)

200.0%

Period: Mar 19, 2025 to Apr 18, 2025. Change in 30 Days versus previous period

Investment in Verrica Pharmaceuticals Shares from India has grown by 200.0% over the past 30 days, indicating increased transactional activity.

73%

Period: Mar 19, 2025 to Apr 18, 2025. Change in 30 Days versus previous period

Search interest for Verrica Pharmaceuticals Stock from India on INDmoney has increased by 73% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Verrica Pharmaceuticals

  • Armistice Capital, LLC

    9.72%

  • Caligan Partners LP

    8.10%

  • Perceptive Advisors LLC

    3.54%

  • BOOTHBAY FUND MANAGEMENT, LLC

    2.82%

  • Vanguard Group Inc

    2.05%

  • BlackRock Inc

    1.30%

Analyst Recommendation on Verrica Pharmaceuticals

Rating
Trend

Buy

    91%Buy

    8%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Verrica Pharmaceuticals(by analysts ranked 0 to 5 stars)

Analyst Forecast on Verrica Pharmaceuticals Stock (VRCA)

What analysts predicted

Upside of 580.27%

Target:

$3.33

Current:

$0.49

Insights on Verrica Pharmaceuticals Stock (Ticker Symbol: VRCA)

  • Price Movement

    In the last 6 months, VRCA stock has moved down by -70.1%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, -1.78M → 344.0K (in $), with an average increase of 617.7% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -22.86M → -16.20M (in $), with an average increase of 41.1% per quarter
  • VRCA vs ONC (1 yr)

    In the last 1 year, Beone Medicines Ltd has given 76.1% return, outperforming this stock by 169.2%
  • VRCA vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 28.9% return, outperforming this stock by 122.6%
  • Price to Sales

    ForVRCA every $1 of sales, investors are willing to pay $3.4, whereas for Beone Medicines Ltd, the investors are paying $6.4 for every $1 of sales.

Verrica Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Verrica Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

Verrica Pharmaceuticals (VRCA) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Verrica Pharmaceuticals Inc logo
-21.43%
-68.76%
-92.97%
-93.23%
-95.36%
Regeneron Pharmaceuticals, Inc. logo
-17.1%
-41.85%
-37.2%
-21.74%
-0.85%
Beone Medicines Ltd logo
-13.12%
5.03%
78.34%
40.23%
43.44%
Vertex Pharmaceuticals Incorporated logo
-4.76%
2.3%
24.05%
71.43%
78.99%
Alnylam Pharmaceuticals, Inc. logo
-9.09%
-19.67%
62.43%
39.66%
61.91%

About Verrica Pharmaceuticals

Verrica Pharmaceuticals Inc., a clinical-stage dermatology therapeutics company, engages in the development and sales of medications for the treatment of skin diseases in the United States. The company's product pipeline comprises YCANTH (VP-102), which is in phase III clinical trial for the common warts; and has completed phase II clinical trial for the treatment of external genital warts. The company also develops VP-315, an oncolytic peptide-based injectable therapy, which is in phase II clinical trial for the treatment of dermatology oncologic conditions which includes basal cell carcinoma; and VP-103, a cantharidin-based product candidate for the treatment of plantar warts and is in phase II clinical trial. In addition, it offers YCANTH for the treatment of molluscum contagiosum. The company has a collaboration and license agreement with Torii Pharmaceutical Co., Ltd. for the development and commercialization of its product candidates for the treatment of molluscum contagiosum and common warts in Japan, including VP-102; and a license agreement with Lytix Biopharma AS to develop and commercialize VP-315 for dermatological oncology indications, such as non-metastatic melanoma and non-metastatic merkel cell carcinoma. Verrica Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in West Chester, Pennsylvania.
Organization
Verrica Pharmaceuticals
Employees
71
CEO
Dr. Jayson M. Rieger M.B.A., Ph.D.
Industry
Health Technology

Management People of Verrica Pharmaceuticals

NameTitle
Mr. Christopher G. Hayes
Chief Legal Officer, Secretary, Chief Compliance Officer & General Counsel
Dr. Jayson M. Rieger M.B.A., Ph.D.
President, CEO & Director
Mr. John J. Kirby CPA
Interim CFO
Mr. David Zawitz
Chief Operating Officer

Important FAQs about investing in VRCA Stock from India :

What is Verrica Pharmaceuticals share price today?

Verrica Pharmaceuticals share price today stands at $0.49, Open: $0.47 ; Previous Close: $0.48 ; High: $0.49 ; Low: $0.44 ; 52 Week High: $11.41 ; 52 Week Low: $0.38.

The stock opens at $0.47, after a previous close of $0.48. The stock reached a daily high of $0.49 and a low of $0.44, with a 52-week high of $11.41 and a 52-week low of $0.38.

Can Indians buy Verrica Pharmaceuticals shares?

Yes, Indians can invest in the Verrica Pharmaceuticals (VRCA) from India.

With INDmoney, you can buy Verrica Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Verrica Pharmaceuticals at zero transaction cost.

How can I buy Verrica Pharmaceuticals shares from India?

It is very easy to buy Verrica Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Verrica Pharmaceuticals (VRCA) be purchased?

Yes, you can buy fractional shares of Verrica Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Verrica Pharmaceuticals stocks?

To start investing in Verrica Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Verrica Pharmaceuticals Stock (VRCA)?

Today’s highest price of Verrica Pharmaceuticals (VRCA) is $0.49.

Today’s lowest price of Verrica Pharmaceuticals (VRCA) is $0.44.

What is today's market capitalisation of Verrica Pharmaceuticals?

Today's market capitalisation of Verrica Pharmaceuticals VRCA is 45.0M

What is the 52 Week High and Low Range of Verrica Pharmaceuticals Stock (VRCA)?

  • 52 Week High

    $11.41

  • 52 Week Low

    $0.38

What are the historical returns of Verrica Pharmaceuticals (VRCA)?

  • 1 Month Returns

    -21.43%

  • 3 Months Returns

    -68.76%

  • 1 Year Returns

    -92.97%

  • 5 Years Returns

    -95.36%

Who is the Chief Executive Officer (CEO) of Verrica Pharmaceuticals ?

Dr. Jayson M. Rieger M.B.A., Ph.D. is the current Chief Executive Officer (CEO) of Verrica Pharmaceuticals.